IMHO our MC is somewhat of a conundrum. Company CEO's who might want to take us over would be laughed at by any BOD if they suggested paying $100 per share for a $26 company. The question would arise "if it is as good as you say, why is it so cheap"? Good question. It is hard for us to attract retail investors because of the uniqueness of our product, the time it will take to get us to market and the interim cash burn. "Yes it might go, but when?" they ask. So they focus on other shorter term gains. Etc Any savvy investors with an eye for the medium to long term (and clearly they are out there) twist Wayne's arm for a discount thus further reducing the sp. (Resulting in squeals from myself and some others. But what's the option?) Because of these obstacles I cannot see any path to riches other than struggling through and getting our product to market, then it's true value will reveal itself. Just my opinion.
- Forums
- ASX - By Stock
- AVR
- Amazing video from the call/presentation today
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Amazing video from the call/presentation today, page-37
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online